ATXA Therapeutics

31/03/2025

ATXA Therapeutics CEO & Founder Therese Kinsella was recently featured in the Business Post discussing the company's current fundraising and the plans to bring NTP42 through clinical trials in patients. Read more here...

ATXA, which is currently in the process of raising the €30 million, has been supported by Enterprise Ireland

28/02/2025

💜🌍 Today is Rare Disease Day! 🌍💜

Together, we stand with the 300 million people worldwide living with rare diseases. In uniting on this day we can raise awareness, advocate for change, and promote a more equitable future! ⚖️

Let’s use this moment to recognise and highlight the voices and stories of the rare disease community.

Share your story. Share your advocacy. Share your voice.

Go to our website to learn more: https://www.rarediseaseday.org/

24/02/2025

Rare is not rare. Taken together, over 300 million people worldwide are affected by a rare disease. on Friday, February 28 calls for equity in access to diagnosis, treatment & care for all people with a rare disease.
Rare Disease Day EURORDIS-Rare Diseases Europe

20/12/2024

On behalf of all of us here at ATXA Therapeutics, we wish you and yours a very happy and peaceful holiday season and the very best for 2025!